Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
Paolo Fusar‐Poli, Cathy Davies, Marco Solmi, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 87

Showing 26-50 of 87 citing articles:

Preferences for Psychological Therapy or Support Within an ARMS Psychological Therapies Trial: The Importance of Targeted Intervention for Unusual Sensory Experiences
Jahnese Hamilton, Akansha Singh, Chris Gibbs, et al.
Early Intervention in Psychiatry (2025) Vol. 19, Iss. 4
Open Access
Antipsychotic Treatment in People at Clinical High Risk for Psychosis
Alessandro Di Lisi, Simona Pupo, Marco Menchetti, et al.
Journal of Clinical Psychopharmacology (2024) Vol. 44, Iss. 5, pp. 502-508
Open Access | Times Cited: 3
Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review
Cristiana Montemagni, Silvio Bellino, Nadja Bracale, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 25
Primary Psychosis: Risk and Protective Factors and Early Detection of the Onset
Claudio Brasso, Benedetta Giordano, Cristina Badino, et al.
Diagnostics (2021) Vol. 11, Iss. 11, pp. 2146-2146
Open Access | Times Cited: 22
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis
Frederike Schirmbeck, Nadine C. van der Burg, Matthijs Blankers, et al.
Schizophrenia Bulletin (2021) Vol. 48, Iss. 1, pp. 100-110
Open Access | Times Cited: 21
Moving from risk to resilience in psychosis research
Katharine N. Thakkar, Amanda McCleery, Kyle S. Minor, et al.
Nature Reviews Psychology (2023) Vol. 2, Iss. 9, pp. 537-555
Closed Access | Times Cited: 8
Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study
Daniel Martins, Cathy Davies, Andrea De Micheli, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Recent Updates on Predicting Conversion in Youth at Clinical High Risk for Psychosis
Noe Caballero, Siddharth Machiraju, Anthony Diomino, et al.
Current Psychiatry Reports (2023) Vol. 25, Iss. 11, pp. 683-698
Open Access | Times Cited: 7
Community Psychosis Risk Screening: An Instrument Development Investigation
Lauren M. Ellman, Jason Schiffman, Vijay A. Mittal
Journal of Psychiatry and Brain Science (2020)
Open Access | Times Cited: 20
Evaluation of variability in individual response to treatments in the clinical high-risk state for psychosis: A meta-analysis
Joaquim Raduà, Cathy Davies, Paolo Fusar‐Poli
Schizophrenia Research (2020) Vol. 227, pp. 20-27
Closed Access | Times Cited: 19
An exploratory study of psychosis risk factors in individuals who are referred but do not meet criteria for an early intervention in psychosis service
Sean Naughton, Aoife Brady, E Geary, et al.
BJPsych Open (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis
Nicholas R Livingston, Amanda Kiemes, Gabriel A. Devenyi, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 9, pp. 1448-1458
Open Access | Times Cited: 2
Transition to psychosis in randomized clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis
Gonzalo Salazar de Pablo, Cathy Davies, Héctor de Diego, et al.
European Psychiatry (2021) Vol. 64, Iss. 1
Open Access | Times Cited: 15
Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review
Borja Pedruzo, Clàudia Aymerich, Malein Pacho, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 10, pp. 3377-3387
Open Access | Times Cited: 6
Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study
Paolo Fusar‐Poli, Andrea De Micheli, Rashmi Patel, et al.
Schizophrenia Bulletin (2020) Vol. 46, Iss. 5, pp. 1114-1125
Open Access | Times Cited: 15
When to initiate antipsychotic treatment for psychotic symptoms: At the premorbid phase or first episode of psychosis?
Tianhong Zhang, Lihua Xu, YanYan Wei, et al.
Australian & New Zealand Journal of Psychiatry (2020) Vol. 55, Iss. 3, pp. 314-323
Closed Access | Times Cited: 14
Clinical High Risk for Psychosis—Not Seeing the Trees for the Wood
Patrick D. McGorry, Barnaby Nelson
JAMA Psychiatry (2020) Vol. 77, Iss. 7, pp. 559-559
Closed Access | Times Cited: 13
The Endocannabinoid System as Modulator of Exercise Benefits in Mental Health
Sandra Amatriain‐Fernández, Henning Budde, Thomas Gronwald, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 8, pp. 1304-1322
Open Access | Times Cited: 12
Childhood Schizotypy and Adolescent Mental Disorder
Kirstie O’Hare, Oliver J. Watkeys, Kimberlie Dean, et al.
Schizophrenia Bulletin (2023) Vol. 50, Iss. 1, pp. 69-77
Open Access | Times Cited: 4
Effects of Diazepam on Hippocampal Blood Flow in People at Clinical High Risk for Psychosis
Nicholas R Livingston, Amanda Kiemes, Gabriel A. Devenyi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Effectiveness of Omega-3 Fatty Acids Versus Placebo in Subjects at Ultra-High Risk for Psychosis: The PURPOSE Randomized Clinical Trial
Inge Winter‐van Rossum, Margot I. E. Slot, Hendrika H. van Hell, et al.
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 1
The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety
Eric Murillo‐Rodríguez, Jocelyne Alcaraz-Silva, Daniel L. Feingold, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 3, pp. 417-430
Closed Access | Times Cited: 7
Managing unusual sensory experiences: A feasibility trial in an At Risk Mental States for psychosis group
Guy Dodgson, Charlotte Aynsworth, Kaja Mitrenga, et al.
Psychology and Psychotherapy Theory Research and Practice (2020) Vol. 94, Iss. 3, pp. 481-503
Open Access | Times Cited: 10
Commentary. Toward a core outcomes assessment set for clinical high risk
Scott W. Woods, Catalina Mourgues, Albert R. Powers
Schizophrenia Research (2020) Vol. 227, pp. 78-80
Open Access | Times Cited: 9
Depression Prevention in Pediatric Primary Care: Implementation and Outcomes of Interpersonal Psychotherapy—Adolescent Skills Training
Rebecca M. Kanine, Morgan L. Bush, Molly Davis, et al.
Child Psychiatry & Human Development (2021) Vol. 54, Iss. 1, pp. 96-108
Closed Access | Times Cited: 9

Scroll to top